% Depreciation & amortization 9,572 9,758 9,749 1.8% -0.1% 27,471 29,374 6.9% (Gain) loss on disposals of PPE -3 0 25 -875% n/a 40 25 -39% Management benefit expense -30 -40 -43 44% 8.5% -112 -123 10% Other
Operating Profit 10,879 9,202 10,063 -7.5% 9.3% 10,024 (39) Depreciation & amortization 8,079 8,919 8,847 10% -0.8% 8,847 - (Gain) loss on disposals of PPE - (20) 29 NA -245% 29 - Management benefit expense
disposals of PPE (3) - 10 -419% NA 157 10 -93% Management benefit expense (48) (48) (56) 17% 17% (82) (104) 26% Other financial cost (16) (6) (12) -25% 117% (38) (18) -54% EBITDA 17,108 18,905 18,998 11% 0.5
30,903 2.8% Depreciation & amortization 7,738 8,325 8,556 11% 2.8% 21,986 24,960 14% (Gain) loss on disposals of PPE - 10 12 NA 12% 157 22 -86% Management benefit expense (36) (56) (41) 13% -26% (119) (145
disposals of PPE - 6 8 n/m 46% Management benefit expense -40 -45 -45 11% -0.3% Other financial cost -5 -4 -5 7.0% 28% EBITDA 22,777 22,234 22,580 -0.9% 1.6% EBITDA margin (%) 53.2% 48.3% 49.2% 6 1Q21 MD&A
% 31,103 30,070 -3.3% Depreciation & amortization 6,262 7,332 7,738 24% 5.5% 14,839 21,986 48% (Gain) loss on disposals of PPE - (3) - NA -100% - 157 NA Management benefit expense (39) (48) (36) -6.6% -24
& amortization 8,556 9,052 9,572 12% 5.8% 24,960 27,471 10% (Gain) loss on disposals of PPE 12 15 (3.2) -127% -121% 22 40 82% Management benefit expense (41) (47) (30) -27% -36% (145) (112) -23% Other financial
& amortization 8,556 9,052 9,572 12% 5.8% 24,960 27,471 10% (Gain) loss on disposals of PPE 12 15 (3.2) -127% -121% 22 40 82% Management benefit expense (41) (47) (30) -27% -36% (145) (112) -23% Other financial
25 6 -98% -77% 372 30 -92% Management benefit expense -33 -43 -45 37% 3.4% -144 -168 16% Other financial cost 0 -4 -4 n/m -0.6% 0 -17 n/m EBITDA 19,366 18,861 19,043 -1.7% 1.0% 78,710 76,619 -2.7
% Depreciation & amortization 4,073 6,828 6,917 70% 1.3% (Gain) loss on disposals of PPE 0 23 160 NA 594% Management benefit expense (36) (41) (34) -3.9% -15% Other financial cost (59) (32) (23) -62% -31% EBITDA